Navigation Links
RSB Spine, LLC, Announces Record 2010 Revenue Growth
Date:1/5/2011

CLEVELAND, Jan. 5, 2011 /PRNewswire/ -- RSB Spine, LLC, a medical device company focused on developing unique modular spinal fusion products for surgical treatment of degenerative disc disease, today announced a 97% sales increase for 2010 versus 2009, with a 184% sales increase for the fourth quarter of 2010 versus the prior-year period.  The company also reports an average growth rate of 33% for five sequential quarters.

RSB Spine Chief Executive Officer John A. Redmond said: "It was a very challenging year for implant companies, and our strong finish and consecutive quarterly growth are a direct result of unique products, great employees and stellar execution by our master distributor Paradigm BioDevices.  Our accomplishments in 2010 position us to achieve our strategic goals for 2011."  

"The InterPlate® platform is gaining rapid market acceptance due to the unique selection of implants available," said Mike O'Neill President & Chief Executive Officer of Paradigm BioDevices. "For the first time surgeons have the freedom to select the flush-fit interbody construct they want and to determine how that construct will behave.  We do not box our surgeons into an implant technology with limited options."  

RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: www.rsbspine.com and www.paradigmbiodevices.com.


'/>"/>
SOURCE RSB Spine, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
2. RSB Spine, LLC, Announces FDA Clearance for the InterPlate(R) C-Ti as an Anterior Cervical Plate
3. RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti
4. Amedica® Corporation Acquires US Spine, Further Securing Its Leadership Position in the Spinal Device Marketplace
5. RSB Spine, LLC, Announces Record Third-Quarter 2010 Revenue and Offering Completion
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):